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Methods: Forty-four FFPE mesothelioma tumors were characterized by Definiens’ Immuno-Oncology Profiling 
(IOP) and NanoString’s GeoMx™ Digital Spatial Profiling. Stainings and image analysis on three alternating 
sequential sections were provided by Definiens’ IOP Panel (CD8/PD-1/FOXP3, CD68/PD-L1/CD3, Granzyme B). 
The resulting IHC multiplex data was used to select T cell and macrophage enriched regions of interest (ROIs) 
with specific co-expression patterns and tumor environments (tumor, stroma, tumor center, invasive margin) 
for high-plex analysis on DSP. Once ROIs were selected, DSP was performed on the sequential section. Each 
slide was stained with a cocktail of pan-cytokeratin, CD3, CD68 and DNA fluorescent markers and a 38 protein 
cocktail of antibodies conjugated to a UV-photocleavable DNA barcodes. For downstream quantitation on the 
NanoString nCounter® platform those barcodes where released by UV excitation of the co-registered ROIs in 
the DSP fluorescent sections.
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Background
Malignant mesothelioma is an aggressive cancer with poor prognosis and few effective therapies. Since mesothelioma is derived from the mesothelium of the lung, we hypothesize that immune cells in the tumor microenvironment (TME) may behave differently than other 
solid tumors. Our previous characterization of mesothelioma samples using multi-plexed immunofluorescence did not reveal specific-immune phenotypes associated with improved patient survival. Here we describe the novel combination of two technologies to spatially 
characterize the interface between mesothelioma cells, stroma and immune cells in the mesothelioma TME in a high-plex capacity.
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Figure 2. Unsupervised hierarchical clustering of Definiens IHC and DSP markers for tumor (left) and stroma region (right) showing a
broader immune marker correlation in the TME. Markers cluster according to immune cell types (macrophages, B-cells, T cells,
tumor cells and other markers.
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Figure 4. (A) 44 mesothelioma samples cluster into 4 dominent expression immune patterns: PD-L1/CD68 dominate, less CD68
with a mix of CD3 and PD-L1 dominate, CD3/CD68 dominate and CD3 domintate, right plot is clustering per patient, left tsne
plot is culstering by marker. (B) DSP images and CD8-enriched ROIs for samples in the CD3 dominate cluster (MESO-043 and
MESO-036). (C) Unsupervised hierarchical clustering of DSP markers for each CD3 dominate sample MESO-043 left, MESO-036
right.
DSP Data Analysis
Results 
• Good correlation between Definiens and 
DSP analysis of T cell and macrophage 
markers confirms the chosen approach 
(Figure 1). 
• IHC and DSP markers cluster by cell types 
including macrophages, T cells, B-cells, 
Tumor and other immune markers (Figure 2)
• Expression of Ki67 is associated with 
decreased OS and CD20 is associated with 
longer OS (Figure 3).
• On a marker co-localization level, we found 
that high CD68 density was tightly 
correlated to PD-L1 expression (Figure 4).
• Mesothelioma samples clustered into four 
categories: PD-L1/CD68, less CD68 with 
CD3/PD-L1, CD3/CD68 and CD3 dominate 
(Figure 4).
• Further analysis of CD3 dominate samples 
express many T cell activation markers and 
very few suppressive markers (Figure 4).
• STING and VISTA were highly expressed 
across mesotheliomas.
Combined Analysis
Definiens and DSP Data
Methods
Methods: Forty-four FFPE mesothelioma tumors were characterized by Definiens’ Immuno-Oncology Profiling (IOP) and NanoString’s GeoMx™ Digital Spatial Profiling. Stainings and image analysis on three alternating sequential sections were provided by Definiens’ IOP
Panel (CD8/PD-1/FOXP3, CD68/PD-L1/CD3, Granzyme B). The resulting IHC multiplex data was used to select T cell and macrophage enriched regions of interest (ROIs) with specific co-expression patterns and tumor environments (tumor, stroma, tumor center, invasive 
margin) for high-plex analysis on DSP. Once ROIs were selected, DSP was performed on the sequential section. Each slide was stained with a cocktail of pan-cytokeratin, CD3, CD68 and DNA fluorescent markers and a 38 protein cocktail of antibodies conjugated to a UV-
photocleavable DNA barcodes. For downstream quantitation on the NanoString nCounter® platform those barcodes where released by UV excitation of the co-registered ROIs in the DSP fluorescent sections.
DSP Analysis Software integrates 
images with count data
Conclusions
• This data set demonstrates how integration 
of two novel high-plex spatial analysis 
techniques separates distinct immune 
mechanisms in mesothelioma TME. 
• We hypothesize that analysis mesotheliomas 
may guide the development of combination 
immunotherapy trials that will be effective 
against this incurable disease.
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Figure 1. Correlation matrix between
overlapping markers for Definiens IHC and
DSP. Generally all markers are well
correlated. On the left is correlation from
ROIs located in the tumor with high CD68
density and low PD-L1 density and the right
is ROIs with high CD8 and high PD-1 density
Results
Figure 3. DSP Marker Counts sorted by Overall Survival (OS) >6 months or <6 months. On the left Ki67 counts were enriched
in patient with OS less than 6 months and poor prognosis. On the right, CD20 was enriched in patients with OS over 6
months and better prognosis.
Patients with Mesothelioma have Distinct Immune Phenotypes
A.
B. CD3 dominated MESO-043 CD3 Dominated MESO-036
C.
Clustering of DSP Markers for MESO-043 Clustering of DSP Markers for MESO-036
CD3
CD68
Pan-CK
DNA
CD3
CD68
Pan-CK
DNA
Definiens selected CD8 dense ROIs
ROI 5                  ROI 7                    ROI 9
ROI 6                   ROI 8                    ROI 10                 
Definiens selected CD8 dense ROIs
ROI 5                  ROI 7                    ROI 9
ROI 6                   ROI 8                    ROI 10                 
